SB 323

  • Maryland Senate Bill
  • 2022 Regular Session
  • Introduced in Senate
  • Passed Senate Mar 17, 2022
  • Passed House Apr 04, 2022
  • Signed by Governor Apr 12, 2022

Public Health - Medications to Treat an Opioid Use Disorder - Preferred and Nonpreferred Medications

Votes


Actions


Apr 12, 2022

Office of the Governor

Approved by the Governor - Chapter 82

Apr 04, 2022

Senate

Returned Passed

House

Third Reading Passed

Apr 01, 2022

House

Favorable Adopted Second Reading Passed

House

Favorable Report by Health and Government Operations

Mar 23, 2022

House

Hearing 3/30 at 1:30 p.m.

Mar 18, 2022

House

Referred Health and Government Operations

Mar 17, 2022

Senate

Third Reading Passed

Mar 16, 2022

Senate

Second Reading Passed with Amendments

Senate

Favorable with Amendments {

Senate

Favorable with Amendments Report by Finance

Jan 21, 2022

Senate

Hearing 2/08 at 1:00 p.m.

Jan 20, 2022

Senate

First Reading Finance

Bill Text

Bill Text Versions Format
First - Maryland Medical Assistance Program - Prior Authorization for Drug Products to Treat an Opioid Use Disorder - Prohibition PDF
Third - Public Health - Medications to Treat an Opioid Use Disorder - Preferred and Nonpreferred Medications PDF
Chapter - Public Health - Medications to Treat an Opioid Use Disorder - Preferred and Nonpreferred Medications PDF

Related Documents

Document Format
Fiscal and Policy Note (Revised) PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Maryland General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.